OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
1
Result
Show all
Save search
Copy query
Show results for
Proteomics
(1)
Organisms
Comana monomorpha
(1)
Pyropia haitanensis
(1)
Klebsiella variicola
(1)
Cytomegalovirus sp.
(1)
Desulfobacula toluolica Tol2
(1)
Mucidula mucida
(1)
Exidia glandulosa HHB12029
(1)
Knufia petricola
(1)
Bacillus subtilis subsp. subtilis NCIB 3610 = ATCC 6051 = DSM 10
(1)
Oomycota
(1)
NEWT:86662
(1)
Portulaca oleracea
(1)
Methanohalophilus
(1)
Legionella pneumophila
(1)
Crunoecia irrorata
(1)
Amycolatopsis
(1)
Laodelphax striatellus
(1)
Nostoc flagelliforme
(1)
Panicum virgatum
(1)
Arion vulgaris
(1)
Streptococcus suis 05ZYH33
(1)
Desulfococcus multivorans DSM 2059
(1)
NEWT:186536
(1)
Neocapritermes taracua
(1)
Metarhizium robertsii ARSEF 2575
(1)
Ensifer meliloti
(1)
Myodes glareolus
(1)
Brenneria nigrifluens
(1)
Campylobacter hepaticus
(1)
Rhizopus delemar
(1)
Repository
pride
(1)
Tissue
Cell culture
(1)
Epithelial cell
(1)
Disease
Breast cancer
(1)
Technology Type
Top-down proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2024
(1)
Lab affiliation
Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Sweden
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
NEDD8 loss causes cancer vulnerability to immune checkpoint blockade in triple-negative breast cancer
We have blocked the expression of some genes in triple-negative breast cancer cell line, MDA-MB-231, and we want to analyse the global protein changes in knockout (KO) versus control cells.
ORGANISM(S):
Homo sapiens (Human)
2024-06-23
|
PXD051061
|
Pride
Human
Pd-1
Triple-negative breast cancer
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
